Compass has already submitted for approval of its psilocybin-based therapy to the FDA following previous Phase III success.

Psilocybin-assisted therapy is emerging as one of the most closely watched approaches for treating depression, with early trials suggesting rapid and sometimes lasting relief after just one or two ...

Two-thirds of clinical trial participants treated with psilocybin-assisted therapy for major depressive disorder were in complete remission from their depression five years later, a new study has ...

Would you want two strangers in the room with you for hours while you're on mushrooms? The federal government just decided ...

A small pilot study from the Center for Psychedelic Research at Imperial College London indicates that psilocybin—the active ...

Research into psychedelics mental health is gaining momentum as scientists explore new approaches to treating conditions like depression and PTSD. Through MAPS trials and psilocybin FDA trials, these ...

VETS Provides Critical Testimony Supporting Nation's Fourth State Program for Psychedelic-Assisted Therapy TRENTON, N.J., Jan. 21, 2026 /PRNewswire-PRWeb/ -- On Tuesday, January 20, New Jersey ...

A single dose of psilocybin eased symptoms of depression within days, with benefits lasting for more than three months compared to placebo, our new study has found. The study, published in the journal ...

Most research studies on demoralization have been conducted among those with a medical diagnosis, most notably those with cancer or in palliative care. In the wake of the COVID-19 pandemic, ...

A small new study suggests that magic mushrooms may one day offer a new treatment for anorexia nervosa, a serious eating ...

Two-thirds of clinical trial participants treated with psilocybin-assisted therapy for major depressive disorder were in complete remission from their depression five years later, a new study has ...